Lv1
58 积分 2024-05-10 加入
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC
13天前
已完结
Dacomitinib-induced purpuric drug eruptions associated with IQGAP1 upregulation in a patient with lung adenocarcinoma
2个月前
已完结
Shengbai oral solution for chemotherapy-induced neutropenia and symptom management in non-small cell lung cancer: A multicenter, randomized, open-label trial
3个月前
已完结
Risk factors for interstitial lung disease in patients with non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors: A systematic review and meta-analysis
3个月前
已完结
Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy
4个月前
已完结
c-Met up-regulates the expression of PD-L1 through MAPK/NF-κBp65 pathway
4个月前
已完结
Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non–small cell lung cancer
4个月前
已完结
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications
8个月前
已完结
c-Met immunohistochemistry as reflex test at diagnosis for non-small cell lung cancer: a real-world experience from a monocentric case series
9个月前
已完结
皖公网安备34019202002308
